Achaogen, Inc.
DelistedCIK 1301501fmd_1020GJDGGJ5TJ7J2P83GC3G3YQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2018, 25 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 20 | 26 | 42 | 11 | 9 |
| Cost of revenue | – | – | – | – | – | – | 0 |
| Gross profit | – | – | – | – | – | – | 9 |
| Research and development | 27 | 23 | 30 | 40 | 74 | 96 | 103 |
| Selling, general and administrative | – | – | – | – | – | 42 | 71 |
| Total operating expenses | 34 | 30 | 40 | 53 | 91 | 138 | 198 |
| Operating income | (16) | (12) | (20) | (27) | (49) | (126) | (189) |
| Interest expense | 2 | 1 | 0 | 1 | 2 | 3 | 2 |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
| Net income | (18) | (13) | (20) | (27) | (71) | (126) | (187) |
| Net income to common shareholders | – | – | – | – | – | (126) | (196) |